摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazine | 55043-49-7

中文名称
——
中文别名
——
英文名称
2-Chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazine
英文别名
2-chloro-3-oxo-3,4-dihydro-1,4-benzothiazine;2-Chlor-3-oxo-3,4-dihydro-2H-1,4-benzothiazin;2-chloro-3,4-dihydro-3-oxo-2H-1,4-benzothiazine;2-chloro-2H-1,4-benzothiazine-3(4H)-one;2-chloro-4H-benzo[1,4]thiazin-3-one;2-Chlor-4H-benzo[1,4]thiazin-3-on;2H-1,4-Benzothiazin-3(4H)-one, 2-chloro-;2-chloro-4H-1,4-benzothiazin-3-one
2-Chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazine化学式
CAS
55043-49-7
化学式
C8H6ClNOS
mdl
——
分子量
199.661
InChiKey
ONZFKCLIDSARQT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    221-223 °C(Solv: acetone (67-64-1))
  • 沸点:
    382.2±42.0 °C(Predicted)
  • 密度:
    1.48±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:0c9f08955039ab3e22bdbbff9bcd023e
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-Chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazine噻吩二氯甲烷四氯化锡 为溶剂, 生成 3-oxo-2-(thien-2-yl)-3,4-dihydro-2H-1,4-benzothiazine
    参考文献:
    名称:
    Thiazine (or oxazine) derivatives and preparation thereof
    摘要:
    式[I]的噻嗪衍生物:其中R.sup.1、R.sup.2、R.sup.4和R.sup.5分别是氢原子;R.sup.3是氢原子或卤原子;X是硫原子;R.sup.6是萘基、含硫的单杂环基团或取代苯基;Z.sup.1是两个氢原子;Z.sup.2是氧原子;A是较低的烷基;R.sup.7和R.sup.8相同或不同,分别是i)氢原子,ii)较低烷基,iii)较低烯基,iv)较低炔基,或v)被取代苯基取代的较低烷基,或者两者与相邻氮原子一起形成含氮的单杂环基团;除了式[I]中R.sup.1、R.sup.2、R.sup.3、R.sup.4和R.sup.5分别是氢原子,X是硫原子,R.sup.6是卤代苯基,Z.sup.1是两个氢原子,Z.sup.2是氧原子,A是较低的烷基,R.sup.7和R.sup.8相同或不同,分别是较低烷基;或者其药学上可接受的盐,具有在脑组织内的钙拮抗活性,并且用于预防和治疗缺血性脑病。
    公开号:
    US05496815A1
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 作用下, 生成 2-Chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazine
    参考文献:
    名称:
    Zahn, Chemische Berichte, 1923, vol. 56, p. 584
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Benzo-fused lactams that promote the release of growth hormone
    申请人:Merck & Co., Inc.
    公开号:US05206235A1
    公开(公告)日:1993-04-27
    There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused lactams as the active ingredient thereof are also disclosed.
    已披露了一些新型化合物,被确定为苯并咪唑内酰胺,可促进人类和动物体内生长激素的释放。这种特性可以用于促进食用动物的生长,使可食用肉制品的生产更加高效,在人类身上,可以增加那些缺乏正常分泌天然生长激素的人的身高。还披露了含有苯并咪唑内酰胺作为活性成分的促生长组合物。
  • A Novel, Convenient Synthesis of 2-Aryl-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazines
    作者:Masanobu Fujita、Atsutoshi Ota、Susumu Ito、Koji Yamamoto、Yoichi Kawashima
    DOI:10.1055/s-1988-27648
    日期:——
    A novel method for the synthesis of 2-aryl-3-oxo-3,4-dihydro-2H-1, 4-benzothiazines consists of a Friedel-Crafts type reaction of substituted benzenes with 2-chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazines. This method is convenient by virtue of its simplicity and the good yields.
    一种合成2-芳基-3-氧代-3,4-二氢-2H-1,4-苯并噻嗪的新方法是将取代苯与2-氯-3-氧代-3,4-二氢-2H-1,4-苯并噻嗪进行Friedel-Crafts类型的反应。该方法因其简单性和良好的产率而便捷。
  • 2-Hetaryl Derivatives of 3-Oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazine
    作者:Konstantin G. Nazarenko、Nataliya A. Shtil、Alexander N. Chernega、Miron O. Lozinskii、Andrey A. Tolmachev
    DOI:10.1055/s-2004-822375
    日期:——
    A new approach for the synthesis of 2-hetaryl derivatives of 3-oxo-3,4-dihydro-2H-1,4-benzothiazines is described. 2-Chloro derivatives of 2a,b were reacted with electron-rich heterocycles 3-14 under basic catalysis (with a slight excess of Et3N) to provide the substitution products 16-36. In the reaction of 2b with 14 and 15, an intermolecular cyclization took place between the amino and ethoxycarbonyl groups, resulting in spiro compounds 35 and 36, respectively.
    描述了一种合成3-氧-3,4-二氢-2H-1,4-苯并噻嗪的2-杂芳衍生物的新方法。2-氯衍生物2a和2b在碱性催化(略微过量的三乙胺)下与富电子的杂环化合物3-14反应,得到取代产物16-36。在2b与14和15的反应中,氨基和乙氧基羧基之间发生了分子间环化,分别生成了螺旋化合物35和36。
  • Naphtho thiazine (or oxaline) derivatives and preparations thereof
    申请人:Tanabe Seiyaku Co., Ltd.
    公开号:US05246929A1
    公开(公告)日:1993-09-21
    Thiazine (or oxazine) derivatives of the formula [I]: ##STR1## wherein R.sup.1 and R.sup.2 are both H or form a naphthalene ring together with the benzene ring; R.sup.3 and R.sup.4 are both H, or one of them is halogen and another is H; X is S or O; R.sup.5 and R.sup.6 are each i) H, ii) lower alkyl, iii) cycloalkyl, iv) substituted phenyl, v) naphthyl, vi) lower alkyl which is substituted by substituted or unsubstituted phenyl, or vii) S-containing heterocyclic group; one of Z.sup.1 and Z.sup.2 is O and another is H.sub.2 ; A is lower alkylene; R.sup.7 and R.sup.8 are each i) H, ii) lower alkyl, iii) lower alkenyl, iv) lower alkynyl, or v) lower alkyl which is substituted by substituted or unsubstituted phenyl, or both form together N-containing heterocyclic group; provided that when both of R.sup.1 and R.sup.2 are H, Z.sup.2 is O and either one of R.sup.5 and R.sup.6 is substituted phenyl, naphthyl or S-containing heterocyclic group, or their salts, which have calcium antagonistic activity within the cerebral tissues and are useful for prophylaxis and treatment of ischemic encephalopathia and/or cerebral neurocyte dyscrasia, and process for preparing said compounds.
    吡嗪(或噁嗪)衍生物的化学式[I]:其中R.sup.1和R.sup.2均为H或者与苯环一起形成一个萘环;R.sup.3和R.sup.4均为H,或其中一个为卤素,另一个为H;X为S或O;R.sup.5和R.sup.6分别为i)H,ii)较低烷基,iii)环烷基,iv)取代苯基,v)萘基,vi)受取代或未取代苯基取代的较低烷基,或者vii)含S的杂环基;Z.sup.1和Z.sup.2中的一个为O,另一个为H.sub.2;A为较低烷基;R.sup.7和R.sup.8分别为i)H,ii)较低烷基,iii)较低烯基,iv)较低炔基,或v)受取代或未取代苯基取代的较低烷基,或者两者一起形成含N的杂环基;但当R.sup.1和R.sup.2均为H时,Z.sup.2为O,且R.sup.5和R.sup.6中的任一者为取代苯基、萘基或含S的杂环基时,或它们的盐,具有对大脑组织内钙拮抗活性,并且适用于缺血性脑病和/或脑神经细胞异常的预防和治疗的化合物的制备方法。
  • Platelet anti-aggregative- and calcium antagonistic
    申请人:Santen Pharmaceutical Co., Ltd.
    公开号:US04584300A1
    公开(公告)日:1986-04-22
    This invention relates to benzothiazine derivatives represented by the formula [I] and salts thereof, which are useful for treatment of cardiovascular diseases. ##STR1##
    本发明涉及由公式[I]表示的苯并噻唑衍生物及其盐,其对治疗心血管疾病有用。 ##STR1##
查看更多